-

Shareholder Alert: Robbins LLP Announces That it is Investigating XL Fleet Corp. (XL) on Behalf of Shareholders

SAN DIEGO & BOSTON--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that it is investigating XL Fleet Corp. (NYSE: XL) to determine whether certain XL Fleet Corp. officers and directors violated the Securities Exchange Act of 1934 and breached their fiduciary duties to the Company. XL Fleet provides vehicle electrification solutions for commercial and municipal fleets in North America. It offers hybrid and plug-in hybrid electric drive systems.

If you suffered a loss due to XL Fleet Corp.'s misconduct, click here.

XL Fleet Corp. (XL) Misled Shareholders About its Business Prospects

XL Fleet formed via merger of XL Hybrids, Inc. and Pivotal Investment Corporation II, a special purpose acquisition company, on December 22, 2020. In its Registration Statement seeking shareholder approval of the merger, Pivotal stated that XL Hybrids relies on a limited number of customers for a large portion of its revenue and that the loss of one or more customers could materially and adversely impact its business operations. The Registration Statement also indicated that delays in design, production, and launch of its products could also harm its business, financial condition, and operating results. After the merger, XL Fleet touted its financial results, stating, "the third quarter of 2020 was the highest for a single quarter in the Company's history," as well as its contracts and product offerings.

On March 3, 2021, Muddy Waters Research published a report alleging that salespeople at XL Fleet Corp. "were pressured to inflate their sales pipelines materially in order to mislead XL's board and investors" and that "customer reorder rates are in reality quite low" due to "poor performance and regulatory issues." Citing interviews with former employees, the report alleges, "at least 18 of 33 customers XL featured were inactive." Muddy Waters also claims that XL Fleet did not generate claimed ROIs for customers and that its technology is "weak." On this news, the Company's share price fell $2.09, or 13%, to close at $13.86 per share on March 3, 2021. The price share continued to decline over two trading sessions to close at $11.17 per share on March 5, 2021.

XL Fleet Corp. (XL) Shareholders Have Legal Options. If you would like more information regarding your rights, please contact Lauren Levi at (800) 350-6003 or llevi@robbinsllp.com, or via our Shareholder Information Form.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against XL Fleet Corp. settles or to receive free alerts about company executives engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

LKQ Corporation Class Action Reminder - Robbins LLP Encourages LKQ Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired LKQ Corporation (NASDAQ: LKQ) common stock between February 27, 2023 and July 23, 2025. LKQ is a global distributor of alternative collision replacement parts, recycled engines, and other vehicle components for the repair of automobiles.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.Wha...

Regencell Bioscience Holdings Limited Class Action Reminder - Robbins LLP Encourages RGC Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Regencell Bioscience Holdings Limited (NASDAQ: RGC) securities between October 28, 2024 and October 31, 2025. Regencell is a purported early-stage bioscience company focused on the research, development, and commercialization of traditional Chinese medicine (“TCM”) for the treatment of attention-deficit/hyperactivity disorder (“ADHD”) and autis...

POET Technologies Inc. Class Action Reminder - Robbins LLP Encourages POET Investors to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POET Technologies Inc. (NASDAQ: POET) securities between April 1, 2026 and 8:57 A.M. ET on April 27, 2026. POET Technologies describes itself as a "design and development company offering photonic integrated packaging solutions based on the POET Optical Interposer™, a novel platform that allows the seamless integration of electronic and photoni...
Back to Newsroom